Concepedia
Statistics
Publications
14
Citations
1.4K
H-Index
13
Active since
1989
Affiliations
New Frontier(Current)
GlaxoSmithKline (United States)
Dana-Farber Cancer Institute
Sheba Medical Center
GlaxoSmithKline (United Kingdom)
Denise Zembryki is an author at New Frontier specializing in pharmacology, medicine, and oncology.
Publications per year
1989–2011
Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
Nancy U. Lin, Véronique Dièras, Devchand Paul et al. · Clinical Cancer Research · 2009 · 663 citations · Full text
Medicine, Oncology, Breast Oncology +15
Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases
Nancy U. Lin, Wolfgang Eierman, Richard Greil et al. · Journal of Neuro-Oncology · 2011 · 160 citations
Medicine, Oncology, Pharmacology +14
Design of potent and selective human cathepsin K inhibitors that span the active site
Scott K. Thompson, Stacie M. Halbert, Mary J. Bossard et al. · Proceedings of the National Academy of Sciences · 1997 · 119 citations
Life Sciences, Biochemistry, Pharmacology +17
An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer
Giuseppe Capri, José Chang, S.-C. Chen et al. · Annals of Oncology · 2009 · 87 citations · Full text
Structure Activity Relationships of 5-, 6-, and 7-Methyl-Substituted Azepan-3-one Cathepsin K Inhibitors
Dennis S. Yamashita, Robert W. Marquis, Ren Xie et al. · Journal of Medicinal Chemistry · 2006 · 71 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +15
1–5 of 14